CIPREC

Buenos Aires, Ciudad Autónoma de Buenos Aire C1061AAS

0 studies enrolling now · 3 studies all time

What they study most

Heart Failure With Preserved Ejection Fraction (HFpEF), Lipoprotein Disorder, Obesity, T2D, Type 2 Diabetes

Studies at this site

• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) — Completed
• A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] — Completed